Manulife (Manufacturers Life Insurance)
HCAT icon

Manulife (Manufacturers Life Insurance)’s Health Catalyst HCAT Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$28K Sell
22,014
-1,572
-7% -$2.96K ﹤0.01% 2785
2025
Q4 		$56.4K Sell
23,586
-1,754
-7% -$4.8K ﹤0.01% 2798
2025
Q3 		$72.2K Sell
25,340
-1,151
-4% -$3.94K ﹤0.01% 2838
2025
Q2 		$99.9K Buy
26,491
+4,341
+20% +$17.1K ﹤0.01% 2757
2025
Q1 		$100K Buy
22,150
+168
+0.8% +$889 ﹤0.01% 2692
2024
Q4 		$155K Sell
21,982
-471
-2% -$3.75K ﹤0.01% 2707
2024
Q3 		$183K Sell
22,453
-709
-3% -$5.12K ﹤0.01% 2702
2024
Q2 		$148K Buy
23,162
+2,164
+10% +$13.9K ﹤0.01% 2710
2024
Q1 		$158K Sell
20,998
-1,183
-5% -$10.8K ﹤0.01% 2677
2023
Q4 		$205K Hold
22,181
– – ﹤0.01% 2617
2023
Q3 		$224K Hold
22,181
– – ﹤0.01% 2527
2023
Q2 		$277K Buy
22,181
+165
+0.7% +$1.97K ﹤0.01% 2411
2023
Q1 		$257K Hold
22,016
– – ﹤0.01% 2404
2022
Q4 		$234K Buy
22,016
+796
+4% +$7.68K ﹤0.01% 2463
2022
Q3 		$206K Sell
21,220
-736
-3% -$9.74K ﹤0.01% 2574
2022
Q2 		$318K Buy
21,956
+764
+4% +$13K ﹤0.01% 2357
2022
Q1 		$554K Sell
21,192
-4,476
-17% -$127K ﹤0.01% 2144
2021
Q4 		$1.02K Buy
25,668
+195
+0.8% +$8.89K ﹤0.01% 1814
2021
Q3 		$1.27M Buy
25,473
+620
+2% +$33.8K ﹤0.01% 1688
2021
Q2 		$1.38M Buy
24,853
+6,010
+32% +$320K ﹤0.01% 1798
2021
Q1 		$881K Sell
18,843
-1,330
-7% -$64.4K ﹤0.01% 1963
2020
Q4 		$878K Buy
20,173
+951
+5% +$35.1K ﹤0.01% 1896
2020
Q3 		$704K Hold
19,222
– – ﹤0.01% 1826
2020
Q2 		$531K Buy
19,222
+8,354
+77% +$231K ﹤0.01% 1939
2020
Q1 		$284K Buy
+10,868
New +$332K ﹤0.01% 2123

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s HCAT Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Health Catalyst (HCAT) stake by 6.7% in Q1 2026, selling an estimated $2.96K and leaving 22,014 shares worth $28K. The position accounts for ﹤0.01% of the portfolio, ranked #2785.

Manulife (Manufacturers Life Insurance) first reported a position in HCAT in Q1 2020 and has held it in 25 quarters since. The position peaked at $1.38M in Q2 2021. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 22,014 shares of Health Catalyst worth $28K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 1,572 Health Catalyst shares in Q1 2026, an estimated $2.96K.
  • Health Catalyst made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2785 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Health Catalyst in Q1 2020 and has held it in 25 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Health Catalyst position peaked at $1.38M in Q2 2021.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.